help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2002-0071
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/7/2761    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levasseur, R.
Right arrow Articles by Karsenty, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levasseur, R.
Right arrow Articles by Karsenty, G.
Endocrinology Vol. 144, No. 7 2761-2764
Copyright © 2003 by The Endocrine Society

Reversible Skeletal Abnormalities in {gamma}-Glutamyl Transpeptidase-Deficient Mice

Regis Levasseur, Roberto Barrios, Florent Elefteriou, Donald A. Glass, II, Michael W. Lieberman and Gerard Karsenty

Departments of Molecular and Human Genetics (R.L., F.E., D.G., G.K.) and Pathology (R.B., M.W.L.), M.D./Ph.D. Program (D.G.), Baylor College of Medicine, Houston, Texas 77030

Address all correspondence and requests for reprints to: Gerard Karsenty, M.D., Ph.D., Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030. E-mail: karsenty{at}bcm.tmc.edu.

{gamma}-Glutamyl transpeptidase (GGT) is a widely distributed ectopeptidase responsible for the degradation of glutathione in the {gamma}-glutamyl cycle. This cycle is implicated in the metabolism of cysteine, and absence of GGT causes a severe intracellular decrease in this amino acid. GGT-deficient (GGT-/-) mice have multiple metabolic abnormalities and are dwarf. We show here that this latter phenotype is due to a decreased of the growth plate cartilage total height resulting from a proliferative defect of chondrocytes. In addition, analysis of vertebrae and tibiae of GGT-/- mice revealed a severe osteopenia. Histomorphometric studies showed that this low bone mass phenotype results from an increased osteoclast number and activity as well as from a marked decrease in osteoblast activity. Interestingly, neither osteoblasts, osteoclasts, nor chondrocytes express GGT, suggesting that the observed defects are secondary to other abnormalities. N-acetylcysteine supplementation has been shown to reverse the metabolic abnormalities of the GGT-/- mice and in particular to restore the level of IGF-1 and sex steroids in these mice. Consistent with these previous observations, N-acetylcysteine treatment of GGT-/- mice ameliorates their skeletal abnormalities by normalizing chondrocytes proliferation and osteoblastic function. In contrast, resorbtion parameters are only partially normalized in GGT-/- N-acetylcysteine-treated mice, suggesting that GGT regulates osteoclast biology at least partly independently of these hormones. These results establish the importance of cysteine metabolism for the regulation of bone remodeling and longitudinal growth.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
K. A. Johnson, W. Yao, N. E. Lane, P. Naquet, and R. A. Terkeltaub
Vanin-1 Pantetheinase Drives Increased Chondrogenic Potential of Mesenchymal Precursors in ank/ank Mice
Am. J. Pathol., February 1, 2008; 172(2): 440 - 453.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas
Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting beta-Catenin from T Cell Factor- to Forkhead Box O-mediated Transcription
J. Biol. Chem., September 14, 2007; 282(37): 27298 - 27305.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Hiramatsu, Y. Asaba, S. Takeshita, Y. Nimura, S. Tatsumi, N. Katagiri, S. Niida, T. Nakajima, S. Tanaka, M. Ito, et al.
Overexpression of {gamma}-Glutamyltransferase in Transgenic Mice Accelerates Bone Resorption and Causes Osteoporosis
Endocrinology, June 1, 2007; 148(6): 2708 - 2715.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Niida, M. Kawahara, Y. Ishizuka, Y. Ikeda, T. Kondo, T. Hibi, Y. Suzuki, K. Ikeda, and N. Taniguchi
{gamma}-Glutamyltranspeptidase Stimulates Receptor Activator of Nuclear Factor-{kappa}B Ligand Expression Independent of Its Enzymatic Activity and Serves as a Pathological Bone-resorbing Factor
J. Biol. Chem., February 13, 2004; 279(7): 5752 - 5756.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society